glp-1 receptor agonists as Treatments for Type 2 Diabetes Classification of currently available glucagon-like
Description
Compare each quarterly panel to your baseline values and previous results
One of the benefits of these medicines over older ones, like sulfonylureas or meglitinides, is that they are less likely to cause low blood sugar levels
Glucocorticoid-induced diabetes mellitus: an important but overlooked problem
Due to the retrospective nature of the data, other confounding factors may have affected the results as well
